NASDAQ:CBMG
Delisted
Cellular Biomedicine Group Stock News
$19.75
+0 (+0%)
At Close: May 27, 2022
This Hedge Fund Bought Cellular Biomedicine Group, Inc. (CBMG) At The Right Time
09:17pm, Wednesday, 27'th Nov 2019
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through November 22nd. Among them, Facebook and Microsoft ranked among the top 3 picks and these
Edited Transcript of CBMG earnings conference call or presentation 6-Nov-19 9:30pm GMT
07:35pm, Friday, 22'nd Nov 2019
Q3 2019 Cellular Biomedicine Group Inc Earnings Call
CBMG: Data from Multiple Myeloma Trial to be Presented at ASH…
09:50am, Friday, 15'th Nov 2019
By David Bautz, PhD NASDAQ:CBMG READ THE FULL CBMG RESEARCH REPORT Business Update Cellular Biomedicine Group, Inc. (NASDAQ:CBMG) is a biopharmaceutical company developing cell-based therapies for can
Baird Downgrades Cellular Biomedicine Gr to Neutral, Lowers Price Target to $19
12:00am, Tuesday, 12'th Nov 2019Cellular Biomedicine Group Announces Receipt of a Preliminary Non-Binding "Going Private" Proposal
03:00pm, Monday, 11'th Nov 2019
NEW YORK and SHANGHAI , Nov. 11, 2019 /PRNewswire/ -- Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development ...
Cellular Biomedicine Group, Inc. (CBMG) CEO Tony Liu on Q3 2019 Results - Earnings Call Transcript
12:00am, Sunday, 10'th Nov 2019Cellular Biomedicine Group Reports Third Quarter of 2019 Financial Results and Business Highlights
09:36pm, Wednesday, 06'th Nov 2019
NEW YORK and SHANGHAI , Nov. 6, 2019 /PRNewswire/ -- Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development ...
Cellular Biomedicine Gr Q3 EPS $(0.82) Misses $(0.67) Estimate
12:00am, Wednesday, 06'th Nov 2019Cellular Biomedicine Group to Report Third Quarter 2019 Results on November 6, 2019
12:00pm, Wednesday, 30'th Oct 2019
NEW YORK and SHANGHAI , Oct. 30, 2019 /PRNewswire/ -- Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development ...
Week In Review: Jiangsu's CTFH Signs $200-Million AI Drug Discovery Pact With Insilico
12:00am, Monday, 14'th Oct 2019Week In Review: Jiangsu's CTFH Signs $200 Million AI Drug Discovery Pact With Insilico
12:00am, Saturday, 12'th Oct 2019Is Cellular Biomedicine Group (NASDAQ:CBMG) A Risky Investment?
02:28pm, Friday, 04'th Oct 2019
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...
Cellular Biomedicine Group Announces New Facility to Expand Research and Development and to Support Clinical Development
12:37pm, Wednesday, 02'nd Oct 2019
- Executing long-term strategy to support clinical development of multiple cell therapy platform technologies in the United States NEW YORK and SHANGHAI , Oct. 2, 2019 /PRNewswire/ -- Cellular Biome
Cellular Biomedicine Group to Present at the 2019 Cantor Global Healthcare Conference
08:30pm, Tuesday, 01'st Oct 2019
NEW YORK and SHANGHAI , Oct. 1, 2019 /PRNewswire/ -- Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development ...
